28.04.2016 17:00:01

DGAP-Stimmrechtsanteile: Probiodrug AG

DGAP-PVR: Correction of a release from 11.11.2014, 13:10 CET/CEST - Probiodrug AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Probiodrug AG

28.04.2016 17:00

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. ---------------------------------------------------------------------------

Probiodrug AG

Halle (Saale), Germany

Handelsregister: Amtsgericht Stendal, HRB 213719 (Commercial Register: Local Court of Stendal, HRB 213719)

ISIN: DE0007921835

Publication pursuant to sec. 26 para 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act)



Correction of publication of notification of voting rights pursuant to sec. 21 para. 1 WpHG (Wertpapierhandelsgesetz - German Securities Trading Act)

3.1

JPMorgan Asset Management (UK) Limited, London, United Kingdom, informed our company pursuant to sec. 21 para. 1 WpHG (German Securities Trading Act) on October 31, 2014, that its voting rights proportion exceeded the threshold of 3% of the voting rights in Probiodrug AG, Weinbergweg 22, 06120 Halle (Saale), Germany, ISIN DE0007921835, on October 30, 2014, and that its voting rights proportion in Probiodrug AG amounted to 3.87% (corresponding to 260,000 voting rights). 3.87% (corresponding to 260,000 voting rights) are to be attributed to JPMorgan Asset Management (UK) Limited pursuant to sec. 22 para. 1 sentence 1 no. 6 WpHG.

Halle (Saale), in April 2016

The Management



28.04.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de

--------------------------------------------------------------------------- Language: English Company: Probiodrug AG Weinbergweg 22 06120 Halle/Saale Germany Internet: www.probiodrug.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------

Nachrichten zu Probiodrug AGmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu Probiodrug AGmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!